Diary

  • Tue
    06
    Sep
    2022

    All dayCentral London


    Format:
    This study day will be held in central London from approx. 10am - 4.30pm.

    Description: This course is designed specifically for those new to cancer, or those wishing to refresh their knowledge. In the morning Elaine looks at the mechanisms of action of chemotherapy, hormone therapy, targeted therapy and immunotherapy. In the afternoon, she describes what biomarkers are, where they’re found, how they’re detected, and what they’re used for.

    Audience: This course is ideal for nurses who are new to caring for cancer patients or who wish to refresh and expand their knowledge. This course is also suitable for anyone involved in cancer research and trials.

    Cost: £150 (materials will be available online for the following 30 days)
    To book, contact: conferenceteam@rmh.nhs.uk

    View the programme

     

  • Tue
    29
    Nov
    2022

    9.15am - 4pmCentral London


    Description:
    Throughout the day, Elaine will guide you through the scientific concepts that underpin many of the most prescribed targeted treatments & immunotherapies for people with solid tumours.

    Treatments include a wide variety of antibody-based therapies targeting cell surface proteins and small molecules targeting various kinases and other proteins involved in cell communication. Elaine will discuss progress to date with checkpoint inhibitors and describe other forms of immunotherapy such as treatment vaccines, CAR T cells and TCR-modified T cells.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
    Cost:
    £150 (materials will be available online for the following 30 days)
    To book, contact: conferenceteam@rmh.nhs.uk
    View a PDF of the programme

  • Thu
    02
    Feb
    2023

    Royal Marsden Hospital, London

    Description: In this study day I describe the unique cellular and genetic features of haematological cancers and cover a diverse range of targeted treatments for leukaemias, lymphomas and multiple myeloma. For each disease I explain the relevant treatments, including a wide range of monoclonal antibodies, bi-specifics and other antibody-based treatments, as well as B cell receptor signalling blockers, and inhibitors of Bcl-2 and FLT3. I explore the potential of immunotherapy with CAR T cells, focusing on ALL, NHL and myeloma.
    Audience: Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
    Cost: £150
    To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
    View a PDF of the programme